DPYD and hyperinsulinemic hypoglycemia, familial, 4: Given that DPD deficiency is a well-established cause of 5-FU-related toxicity, carriers of this CNV both at a heterozygote and homozygote state, are potentially at risk for experiencing severe adverse effects of FP treatment.